Standard BioTools Inc. (NASDAQ: LAB)
$2.26
+0.1500 ( +7.11% ) 2.8M
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
Market Data
Open
$2.26
Previous close
$2.11
Volume
2.8M
Market cap
$837.15M
Day range
$2.07 - $2.29
52 week range
$1.57 - $3.16
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k/a | Quarterly Reports | 17 | Apr 26, 2024 |
8-k | 8K-related | 14 | Apr 25, 2024 |
4 | Insider transactions | 1 | Apr 09, 2024 |
4 | Insider transactions | 1 | Apr 05, 2024 |
4 | Insider transactions | 1 | Apr 05, 2024 |
4 | Insider transactions | 1 | Mar 20, 2024 |
3 | Insider transactions | 1 | Mar 20, 2024 |
8-k | 8K-related | 17 | Mar 18, 2024 |
4 | Insider transactions | 1 | Mar 06, 2024 |
10-k | Annual reports | 113 | Mar 01, 2024 |